5-HTP 100 mg
Natural health product licensed in Canada
- Licence holder
- Nestle Canada Inc. dba (Atrium Innovations/Genestra Brands/Pure Encapsulations/Garden of Life Canada/Trophic Canada/SISU/Wobenzym/Bountiful Canada Vitamins/Nature's Bounty/Vital Proteins Canada)
- NPN or DIN-HM
- 80003384
- Status
- Active licence
- Licence date
- 10 May 2007
- Revision date
- 24 July 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine, phosphate de dicalcium, Stéarate de magnésium, Croscarmellose de sodium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
| Adultes | Not specified | 3 Capsule | 3 Tous les jours |
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to relieve symptoms of fibromyalgia. Helps to reduce the severity & duration of migraine headaches when taken as a prophylactic. Helps to promote healthy mood balance. Used as a sleep aid. To be used with a program of reduced intake of dietary calories & increased physical activity to help in weight management by reducing carbohydrate cravings.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have scleroderma.
- Précautions et mises en garde
ALL USES: Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking carbidopa or drugs / supplements with serotonergic activity. These may include, but are not limited to, L-tryptophan, S-adenosylmethionine (SAMe), St. John's wort, antidepressants, pain killers, over the counter cough & cold medication containing dextromethorphan, anti-nausea medication & anti-migraine medication. Discontinue use & consult a health care practitioner if you show signs of weakness, oral ulcers or abdominal pain accompanied by severe muscle pain or if you experience skin changes. SLEEP AID: Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks.
Source
Official Health Canada record, licence 80003384
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging